Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

[18F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancer

Lookup NU author(s): Dr Jingky Lozano-KuehneORCiD

Downloads

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Publication metadata

Author(s): Sharma R, Valls PO, Inglese M, Dubash S, Chen M, Gabra H, Montes A, Challapalli A, Arshad M, Tharakan G, Chambers E, Cole T, Lozano-Kuehne JP, Barwick TD, Aboagye EO

Publication type: Article

Publication status: Published

Journal: European Journal of Nuclear Medicine and Molecular Imaging

Year: 2020

Volume: 47

Pages: 1239–1251

Print publication date: 01/05/2020

Online publication date: 21/11/2019

Acceptance date: 11/09/2019

Date deposited: 27/01/2023

ISSN (print): 1619-7070

ISSN (electronic): 1619-7089

Publisher: Springer

URL: https://doi.org/10.1007/s00259-019-04532-z

DOI: 10.1007/s00259-019-04532-z

Altmetrics

Altmetrics provided by Altmetric

Funding

Funder referenceFunder name
GSK/Novartis
GE Healthcare
MC_U120081322
MR/N020782/1)

Share